Objective To examine whether and how the COVID-19 pandemic affected the use of
antipsychotics among residents with Alzheimer's disease and related dementias in nursing …

Objectives This study aimed to determine the impact of the Covid‐19 pandemic on
neuropsychiatric symptoms and antipsychotic use in people with dementia living in nursing …

Importance Concerns have been raised that the use of antipsychotic medication for people
living with dementia might have increased during the COVID-19 pandemic. Objective To …

Objectives Following the 2012 launch of the National Partnership to Improve Dementia Care
in Nursing Homes (the National Partnership), the use of antipsychotics has declined …

Objectives To examine the associations between COVID-19 pandemic waves (1–4) and
prevalent antipsychotic, antidepressant, benzodiazepine, anticonvulsant, and opioid use …

Background The COVID‐19 pandemic significantly disrupted nursing home (NH) care,
including visitation restrictions, reduced staffing levels, and changes in routine care. These …

In Reply We appreciate Chu et al for their interest in and perspective on our study. 1 We
wish to highlight a few points to clarify the purpose of our research, emphasize the …

Residents of long-term care facilities (LTCFs), including nursing homes and assisted living
facilities, were disproportionately affected by the COVID-19 pandemic. Since the start of the …

Importance The COVID-19 pandemic caused large disruptions to health care for
hospitalized older adults. The incidence and management of delirium may have been …

Objectives We examined the association between nursing home (NH) characteristics and
whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing …